AMERICAN drugmaker Novavax has applied for an emergency use authorization (EUA) for its Covovax or NVX-Cov2373 vaccine.
Food and Drug Administration (FDA) Director General Rolando Enrique Domingo said during a briefing on Monday the agency started evaluating the vaccine after its local distributor, Faberco Life Sciences Inc., submitted some required documents last week.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.